Insider Trading activities of Renovis Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Renovis Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Renovis Inc since year 2005. Table 2 shows the detailed insider transactions of Renovis Inc since 2005. The reporting company's ticker symbol is RNVS. The reporting company's CIK number is 1118361.
The total value of stock buying since 2005 is $2,106,508.
The total value of stock sales since 2005 is $31,827,677.
The total value of stock option exercises since 2005 is $214,776.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Renovis Inc (RNVS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-04 20,000 $45,598 800,000 $1,788,000 0 $0
2008-03 113,446 $259,844 0 $0 0 $0
2008-02 750,998 $1,801,066 0 $0 0 $0
2006-12 0 $0 40,000 $123,200 0 $0
2006-11 0 $0 51,852 $168,011 0 $0
2006-10 0 $0 51,649 $247,512 0 $0
2006-09 0 $0 6,000 $88,176 0 $0
2006-08 0 $0 6,000 $73,710 0 $0
2006-07 0 $0 6,000 $92,118 0 $0
2006-06 0 $0 6,000 $97,638 0 $0
2006-05 0 $0 8,650 $149,256 58,911 $72,872
2006-04 0 $0 24,150 $493,675 79,353 $84,834
2006-03 0 $0 702,150 $15,107,394 21,000 $36,410
2006-02 0 $0 33,500 $706,875 10,000 $11,250
2006-01 0 $0 27,150 $491,815 1,000 $9,410
2005-12 0 $0 7,650 $121,301 0 $0
2005-11 0 $0 16,650 $234,240 0 $0
2005-10 0 $0 8,650 $116,252 0 $0
2005-09 0 $0 8,650 $114,486 0 $0
2005-08 0 $0 9,650 $143,231 0 $0
2005-07 0 $0 20,650 $312,057 0 $0
2005-06 0 $0 17,050 $234,307 0 $0
2005-05 0 $0 685,554 $10,924,423 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Renovis Inc insiders (RNVS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-04-22 Mm Asset Management Inc. (10% Owner) Buy 10,000 2.28 22,799
2008-04-22 Mm Asset Management Inc. (10% Owner) Sale 400,000 2.24 894,000
2008-04-22 Mmcap International Inc. Spc (10% Owner) Buy 10,000 2.28 22,799
2008-04-22 Mmcap International Inc. Spc (10% Owner) Sale 400,000 2.24 894,000
2008-03-07 Mm Asset Management Inc. (10% Owner) Buy 28,400 2.28 64,610
2008-03-07 Mmcap International Inc. Spc (10% Owner) Buy 28,400 2.28 64,610
2008-03-03 Mm Asset Management Inc. (10% Owner) Buy 28,323 2.31 65,312
2008-03-03 Mmcap International Inc. Spc (10% Owner) Buy 28,323 2.31 65,312
2008-02-21 Mm Asset Management Inc. (10% Owner) Buy 14,834 2.44 36,194
2008-02-21 Mmcap International Inc. Spc (10% Owner) Buy 14,834 2.44 36,194
2008-02-20 Mm Asset Management Inc. (10% Owner) Buy 79,701 2.46 196,462
2008-02-20 Mmcap International Inc. Spc (10% Owner) Buy 79,701 2.46 196,462
2008-02-13 Mm Asset Management Inc. (10% Owner) Buy 12,402 2.56 31,687
2008-02-13 Mmcap International Inc. Spc (10% Owner) Buy 12,402 2.56 31,687
2008-02-12 Mm Asset Management Inc. (10% Owner) Buy 165,000 2.39 393,855
2008-02-12 Mmcap International Inc. Spc (10% Owner) Buy 165,000 2.39 393,855
2008-02-11 Mm Asset Management Inc. (10% Owner) Buy 103,562 2.34 242,335
2008-02-11 Mmcap International Inc. Spc (10% Owner) Buy 103,562 2.34 242,335
2006-12-15 Walker John Peter (Director) Sale 40,000 3.08 123,200
2006-11-20 Goodman Corey S (President and CEO) Sale 1,852 3.38 6,261
2006-11-02 Doyle John C (SVP, Finance/Operations & CFO) Sale 50,000 3.24 161,750
2006-10-27 Goodman Corey S (President and CEO) Sale 20,649 3.52 72,663
2006-10-26 Goodman Corey S (President and CEO) Sale 25,000 3.74 93,525
2006-10-02 Goodman Corey S (President and CEO) Sale 6,000 13.55 81,324
2006-09-01 Goodman Corey S (President and CEO) Sale 6,000 14.70 88,176
2006-08-01 Goodman Corey S (President and CEO) Sale 6,000 12.28 73,710
2006-07-03 Goodman Corey S (President and CEO) Sale 6,000 15.35 92,118
2006-06-01 Goodman Corey S (President and CEO) Sale 6,000 16.27 97,638
2006-05-25 Doyle John C (VP, Finance & CFO) Option Ex 10,300 1.24 12,741
2006-05-16 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 15.70 15,700
2006-05-03 Pathak Dushyant (VP, Corporate Development) Option Ex 48,611 1.24 60,131
2006-05-02 Serafini Tito (VP, Technology) Sale 1,650 17.06 28,148
2006-05-01 Goodman Corey S (President and CEO) Sale 6,000 17.57 105,408
2006-04-17 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 18.65 18,650
2006-04-12 Doyle John C (VP, Finance & CFO) Option Ex 30,000 1.24 37,110
2006-04-12 Goodman Corey S (President and CEO) Option Ex 49,353 .97 47,724
2006-04-06 Goodman Corey S (President and CEO) Sale 12,500 20.29 253,625
2006-04-03 Goodman Corey S (President and CEO) Sale 9,000 20.80 187,245
2006-04-03 Serafini Tito (VP, Technology) Sale 1,650 20.70 34,155
2006-03-20 Pathak Dushyant (VP, Corporate Development) Sale 2,000 24.00 48,000
2006-03-16 Kelly Michael Gerald (SVP, Research & Development) Sale 4,000 23.38 93,520
2006-03-16 Doyle John C (VP, Finance & CFO) Sale 20,000 23.37 467,440
2006-03-16 Doyle John C (VP, Finance & CFO) Option Ex 20,000 1.35 27,000
2006-03-15 Perry Marlene F (Vice President, Human Resource) Sale 1,000 22.72 22,720
2006-03-15 Perry Marlene F (Vice President, Human Resource) Option Ex 1,000 9.41 9,410
2006-03-06 Goodman Corey S (President and CEO) Sale 25,000 21.94 548,624
2006-03-02 Serafini Tito (VP, Technology) Sale 3,650 22.00 80,300
2006-03-02 Penhoet Edward (Director) Sale 625,000 21.40 13,375,000
2006-03-01 Goodman Corey S (President and CEO) Sale 9,000 21.94 197,478
2006-02-27 Walker John Peter (Director) Sale 20,000 21.72 434,340
2006-02-16 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 20.36 20,360
2006-02-08 Doyle John C (VP, Finance & CFO) Option Ex 10,000 1.12 11,250
2006-02-06 Goodman Corey S (President and CEO) Sale 12,500 20.17 252,175
2006-01-26 Perry Marlene F (Vice President, Huma) Sale 1,000 20.00 20,000
2006-01-26 Perry Marlene F (Vice President, Huma) Option Ex 1,000 9.41 9,410
2006-01-26 Goodman Corey S (President and CEO) Sale 2,439 20.00 48,780
2006-01-25 Goodman Corey S (President and CEO) Sale 561 20.00 11,220
2006-01-25 Serafini Tito (VP, Chief Discovery) Sale 2,000 20.00 40,000
2006-01-18 Goodman Corey S (President and CEO) Sale 12,500 19.00 237,500
2006-01-17 Kelly Michael Gerald (VP, Drug Discovery) Sale 1,000 18.18 18,180
2006-01-03 Goodman Corey S (President and CEO) Sale 6,000 15.18 91,110
2006-01-03 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.17 25,025
2005-12-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.88 26,195
2005-12-01 Goodman Corey S (President and CEO) Sale 6,000 15.85 95,106
2005-11-17 Kelly Michael Gerald (VP, Drug Discovery) Sale 6,000 13.96 83,790
2005-11-15 Kelly Michael Gerald (VP, Drug Discovery) Sale 3,000 15.00 45,000
2005-11-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.64 22,506
2005-11-01 Goodman Corey S (President and CEO) Sale 6,000 13.82 82,944
2005-10-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 12.92 12,920
2005-10-03 Goodman Corey S (President and CEO) Sale 6,000 13.51 81,048
2005-10-03 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.51 22,284
2005-09-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.10 13,100
2005-09-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.26 21,880
2005-09-01 Goodman Corey S (President and CEO) Sale 6,000 13.25 79,506
2005-08-22 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.43 13,430
2005-08-10 Moreadith Randall (Chief Medical Office) Sale 1,000 13.30 13,300
2005-08-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.24 25,139
2005-08-01 Goodman Corey S (President and CEO) Sale 6,000 15.23 91,362
2005-07-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 16.20 16,200
2005-07-05 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.06 24,849
2005-07-01 Goodman Corey S (President and CEO) Sale 12,000 15.06 180,672
2005-06-24 Kelly Michael Gerald (VP, Drug Discovery) Sale 3,000 15.00 45,000
2005-06-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 14.69 14,690
2005-06-15 Moreadith Randall (Chief Medical Office) Sale 5,400 13.34 72,063
2005-06-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 12.96 21,392
2005-06-01 Goodman Corey S (President and CEO) Sale 6,000 13.53 81,162
2005-05-23 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 17.25 17,250
2005-05-12 Walker John Peter (Director) Sale 10,000 18.00 180,000
2005-05-10 Crowell Nancy M (Director) Sale 249,000 16.96 4,099,386
2005-05-09 Crowell Nancy M (Director) Sale 150,000 15.65 2,347,949
2005-05-06 Scolnick Edward M (Director) Sale 80,000 14.50 1,159,600
2005-05-04 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.50 13,500
2005-05-04 Goodman Corey S (President and CEO) Sale 6,000 14.73 88,380

Insider trading activities including stock purchases, stock sales, and option exercises of RNVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Renovis Inc (symbol RNVS, CIK number 1118361) see the Securities and Exchange Commission (SEC) website.